Microbio Co (ROCO:4128) Total Liabilities: NT$2,129 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4128 Microbio Co Ltd ROCO:4128
56 GF Score
Price NT$15.85
GF Value NT$45.77
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Microbio Co Total Liabilities?

Microbio Co ROCO:4128 -1.55% 56 Total Liabilities is NT$2,129 Mil as of Dec. 2025. GuruFocus rates ROCO:4128 with a GF Score™ of 56/100 and a GF Value™ of NT$45.77 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Microbio Co's Total Liabilities for the quarter that ended in Dec. 2025 was NT$2,129 Mil.

Microbio Co's quarterly Total Liabilities increased from Jun. 2025 (NT$1,839.36 Mil) to Sep. 2025 (NT$2,038.68 Mil) and increased from Sep. 2025 (NT$2,038.68 Mil) to Dec. 2025 (NT$2,129.32 Mil).

Microbio Co's annual Total Liabilities increased from Dec. 2023 (NT$1,234.69 Mil) to Dec. 2024 (NT$2,057.93 Mil) and increased from Dec. 2024 (NT$2,057.93 Mil) to Dec. 2025 (NT$2,129.32 Mil).

Microbio Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Microbio Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbio Co Total Liabilities Chart

Microbio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,173.05 1,082.42 1,234.69 2,057.93 2,129.32

Microbio Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,057.93 1,960.06 1,839.36 2,038.68 2,129.32
ROCO:4128
56GF Score
Microbio Co Ltd ROCO:4128
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbio Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Microbio Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=791.987+(520.808+764.054
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+52.466+0)
=2,129

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=12333.802-10204.487
=2,129

Microbio Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=791.987+(520.808+764.054
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+52.466+0)
=2,129

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=12333.802-10204.487
=2,129

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$2,129 Mil mean?
Microbio Co (ROCO:4128) has a Total Liabilities of NT$2,129 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Microbio Co and its competitors.
Is Microbio Co's Total Liabilities too high?
Microbio Co's current Total Liabilities is NT$2,129 Mil. Overall, Microbio Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Microbio Co's Total Liabilities compare to KHC and GIS?
Microbio Co's Total Liabilities of NT$2,129 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Microbio Co and its competitors. Microbio Co's current Total Liabilities is NT$2,129 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbio Co stock overvalued right now?
Based on GuruFocus' analysis, Microbio Co (ROCO:4128) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$45.77, compared to a current price of NT$15.85 — trading 65.4% below its estimated fair value. The current Total Liabilities is NT$2,129 Mil. Microbio Co's overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Microbio Co (ROCO:4128), the current Total Liabilities is NT$2,129 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbio Co (ROCO:4128) Overvalued in 2026?

Based on GuruFocus' analysis, Microbio Co stock appears to be undervalued. The current stock price of NT$15.85 is trading 65.4% below its estimated GF Value™ of NT$45.77. GuruFocus considers Microbio Co to be Significantly Undervalued.

Key valuation signals for ROCO:4128:

  • Total Liabilities: NT$2,129 Mil
  • GF Value™: NT$45.77 vs. price of NT$15.85 (65.4% below fair value)
  • GF Score™: 56/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbio Co Business Description

Address Yuanqu Street, No. 3, 18th Floor - 1, Sanchong Village, Nangang District, Taipei, TWN
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
56GF Score

Get the complete analysis for ROCO:4128

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.85
Price
NT$45.77
GF Value